Alpha-Lipoic Acid Dosage: What Neuropathy Trials Used

Alpha-lipoic acid amounts used in research

Figures are amounts reported in the cited sources, not a personal recommendation. Your own amount depends on your health, medicines and blood work.

Why 600 mg became the standard

Alpha-lipoic acid was studied intensively in Germany for diabetic neuropathy, first intravenously and then orally. The oral programme settled on 600 mg per day because that was where symptom improvement appeared without the dose-dependent nausea seen higher up.

SYDNEY 2 tested this directly by randomising 600, 1,200 and 1,800 mg per day against placebo. All three active arms improved neuropathic symptom scores similarly, while gastrointestinal side effects climbed with dose.

That is a rare and useful finding: the trial that could have justified taking more is the trial that argues against it.

• 600 mg per day is the researched oral amount
• 1,200 and 1,800 mg gave no extra benefit
• Nausea and vomiting rose with dose
• Taken before food in the trial protocols

R-lipoic acid, racemic mixtures and what the labels mean

Lipoic acid exists as two mirror-image forms. The body makes and uses the R form; most supplements — and most of the trials — used a racemic mixture containing both R and S in equal parts.

R-lipoic acid products are marketed as the 'active' form and reach higher peak plasma concentrations, but they are also less chemically stable, and the clinical outcome data sit with the racemic material used in the neuropathy trials.

Sodium R-lipoate improves stability and absorption further. None of these forms has an outcome trial matching the racemic evidence base, so buying the researched form is the conservative choice.

Blood sugar, and why that matters practically

Alpha-lipoic acid has been reported to improve insulin sensitivity and lower blood glucose in some studies. For someone with diabetes on glucose-lowering medication, that is not purely a benefit — it is an additive effect on top of a treatment already titrated to their readings.

Anyone using insulin or a sulfonylurea should raise it with their prescriber before starting and watch for hypoglycaemia in the first weeks.

Longer trials such as NATHAN 1, running four years at 600 mg per day, found the dose tolerable over time, which is reassuring on safety even though its primary endpoint was not met.

Side effects and the insulin autoimmune syndrome caution

The usual complaints are nausea, vomiting, heartburn and rash, all more common at higher doses. Skin reactions have been described occasionally.

The unusual one is insulin autoimmune syndrome, a rare condition in which antibodies to insulin cause hypoglycaemia. It has been associated with sulfhydryl-containing compounds including alpha-lipoic acid, most often reported in people of Japanese and Korean genetic background carrying particular HLA types.

This is rare enough that it should not deter most people, and specific enough that it belongs in an honest safety summary.

Alpha-lipoic acid may also affect thyroid hormone handling and can chelate metals, which is why it is usually separated in time from thyroid medication and mineral supplements.

How to use it sensibly

If your reason for taking it is neuropathic symptoms, that is a clinical situation that deserves a diagnosis and a management plan; alpha-lipoic acid is at most one part of it.

Keep the dose at the researched 600 mg per day, take it before food, and give it a defined period with tracked symptoms rather than an indefinite habit.

Separate it from levothyroxine and from iron, calcium, magnesium or zinc by several hours, and log it so it appears on the list you show your prescriber.

What the published studies found

Each entry below links straight to the paper or the health authority page so you can read the original rather than take our word for it.

• Ziegler D et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy (SYDNEY 2). Diabetes Care. 2006.

  Randomised, double-blind, placebo-controlled trial, 181 patients, 5 weeks

  600, 1,200 and 1,800 mg per day all improved Total Symptom Score versus placebo; higher doses added nausea and vomiting without added benefit, supporting 600 mg as the practical dose.

• Ziegler D et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years (NATHAN 1). Diabetes Care. 2011.

  Randomised, double-blind, placebo-controlled trial, 460 patients, 4 years

  600 mg per day was well tolerated over four years; the primary composite endpoint was not met, though some neuropathic impairment measures improved.

• Linus Pauling Institute Micronutrient Information Center. Lipoic Acid.

  Authoritative review of lipoic acid biochemistry, pharmacokinetics and trials

  Documents reduced absorption when taken with food, the difference between R and racemic preparations, and the concentration of clinical evidence in diabetic neuropathy.

Side effects reported in the literature

Summarized from Linus Pauling Institute — Lipoic Acid. Report anything unexpected to your own doctor or pharmacist.

Interactions to check with a pharmacist

This is not a complete interaction list. Check your own medicines with a pharmacist before combining anything.

Frequently asked questions

Keep reading

• Berberine dosage guide
• Magnesium glycinate dosage
• CoQ10 dosage guide

Sources

1. Linus Pauling Institute Micronutrient Information Center. Lipoic Acid.
2. Ziegler D et al. SYDNEY 2 trial. Diabetes Care. 2006.
3. Ziegler D et al. NATHAN 1 trial. Diabetes Care. 2011.
4. NIH Office of Dietary Supplements. Dietary Supplements for Diabetes.